About Pyrexar medical
Pyrexar Medical: Revolutionizing Cancer Care with Hyperthermia Systems
Cancer is one of the most dreaded diseases in the world, affecting millions of people every year. Despite significant advances in medical science, cancer remains a major challenge for healthcare professionals and patients alike. However, there is hope on the horizon thanks to Pyrexar Medical, a leading provider of hyperthermia systems that are making a real difference in cancer care.
Founded in 2006 by Mark Falkowski and Paul Turner, Pyrexar Medical has quickly established itself as a pioneer in hyperthermia technology. The company's mission is to improve patient outcomes by providing innovative solutions that enhance the effectiveness of radiation therapy and chemotherapy.
Hyperthermia therapy involves heating tumors to temperatures between 40-45°C (104-113°F) using electromagnetic waves or ultrasound. This localized heat can shrink tumors by damaging cancer cells while sparing healthy tissue. Hyperthermia can also increase blood flow to tumors, making them more susceptible to radiation and chemotherapy.
Pyrexar Medical offers two types of hyperthermia systems: BSD-2000 Deep Regional Hyperthermia (DRHT) system and BSD-500 Superficial/Interstitial Hyperthermia (SIH) system. The DRHT system delivers heat deep into tissues up to 8 cm below the skin surface while the SIH system targets superficial or deep-seated tumors up to 3 cm below the skin surface.
The BSD-2000 DRHT system uses radiofrequency energy delivered through multiple antennas placed around or near the tumor site. The antennas generate an electromagnetic field that heats tumor tissue while minimizing damage to surrounding healthy tissue. The BSD-500 SIH system uses microwave energy delivered through an array of antennas placed directly on or near the tumor site.
Clinical studies have shown that hyperthermia therapy can significantly improve treatment outcomes for various types of cancers such as breast cancer, cervical cancer, bladder cancer, head and neck cancers among others when used alongside radiation therapy or chemotherapy.
Pyrexar Medical's hyperthermia systems have been used successfully in many countries worldwide including Europe where they are widely accepted as standard care for certain types of cancers such as cervical cancer.
In addition to its cutting-edge technology solutions for oncology treatment centers worldwide Pyrexar medical provides comprehensive training programs for physicians nurses physicists biomedical engineers who want learn how use their equipment effectively safely efficiently so they can provide best possible care their patients
Pyrexar Medical has received numerous awards over years including Frost & Sullivan's North American Technology Innovation Award which recognizes companies that have developed innovative products technologies meet needs customers industry-wide
In conclusion Pyrexar medical is revolutionizing Cancer Care with ground breaking hyperthemia systems which are backed by clinical studies proving localized heat can shrink tumours . With its commitment towards innovation quality safety efficiency it continues lead way improving patient outcomes across globe .